JP2023530456A5 - - Google Patents
Info
- Publication number
- JP2023530456A5 JP2023530456A5 JP2022577582A JP2022577582A JP2023530456A5 JP 2023530456 A5 JP2023530456 A5 JP 2023530456A5 JP 2022577582 A JP2022577582 A JP 2022577582A JP 2022577582 A JP2022577582 A JP 2022577582A JP 2023530456 A5 JP2023530456 A5 JP 2023530456A5
- Authority
- JP
- Japan
- Prior art keywords
- degrees
- crystal morphology
- peaks
- xrpd pattern
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063040277P | 2020-06-17 | 2020-06-17 | |
| US63/040,277 | 2020-06-17 | ||
| PCT/US2021/037535 WO2021257643A1 (en) | 2020-06-17 | 2021-06-16 | Crystalline forms of a cd73 inhibitor and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023530456A JP2023530456A (ja) | 2023-07-18 |
| JP2023530456A5 true JP2023530456A5 (https=) | 2024-06-24 |
Family
ID=76845331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577582A Pending JP2023530456A (ja) | 2020-06-17 | 2021-06-16 | Ｃｄ７３阻害剤の結晶形態及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11649261B2 (https=) |
| EP (1) | EP4168120A1 (https=) |
| JP (1) | JP2023530456A (https=) |
| KR (1) | KR20230026312A (https=) |
| CN (1) | CN115942977A (https=) |
| AU (1) | AU2021292195A1 (https=) |
| CA (1) | CA3179320A1 (https=) |
| WO (1) | WO2021257643A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017120508A1 (en) | 2016-01-08 | 2017-07-13 | Arcus Biosciences, Inc. | Modulators of 5'-nucleotidase, ecto and the use thereof |
| EP3893891A4 (en) | 2018-12-13 | 2022-08-03 | Arcus Biosciences, Inc. | SOLID FORMS OF A CD73 INHIBITOR AND THEIR USE |
| CN113795267A (zh) * | 2019-03-12 | 2021-12-14 | 艾库斯生物科学有限公司 | 致癌基因驱动的癌症的治疗 |
| WO2020205527A1 (en) | 2019-03-29 | 2020-10-08 | Arcus Biosciences, Inc. | Treatment of cancer utilizing an identified adenosine fingerprint |
| US11633416B1 (en) | 2020-03-06 | 2023-04-25 | Arcus Biosciences, Inc. | Oral formulations of CD73 compounds |
| KR20230026312A (ko) * | 2020-06-17 | 2023-02-24 | 아르커스 바이오사이언시즈 인코포레이티드 | Cd73 억제제의 결정형 및 이의 용도 |
| JP2025512384A (ja) | 2022-04-13 | 2025-04-17 | ギリアード サイエンシーズ， インコーポレイテッド | Ｔｒｏｐ－２発現がんを治療するための併用療法 |
| US20240180947A1 (en) | 2022-10-20 | 2024-06-06 | Arcus Biosciences, Inc. | Lyophilized formulations of cd73 compounds |
| WO2025137640A1 (en) | 2023-12-22 | 2025-06-26 | Gilead Sciences, Inc. | Azaspiro wrn inhibitors |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1248869A2 (en) * | 2000-01-07 | 2002-10-16 | Transform Pharmaceuticals, Inc. | High-throughput formation, identification, and analysis of diverse solid-forms |
| ES2722300T3 (es) | 2009-12-10 | 2019-08-09 | Hoffmann La Roche | Anticuerpos que se unen preferentemente al dominio extracelular 4 de CSF1R y su uso |
| US9169323B2 (en) | 2010-03-05 | 2015-10-27 | Hoffmann-La Roche Inc. | Antibodies against human CSF-1R |
| JP5989547B2 (ja) | 2010-03-05 | 2016-09-07 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | ヒトｃｓｆ−１ｒに対する抗体及びその使用 |
| HRP20190047T1 (hr) | 2010-05-04 | 2019-02-22 | Five Prime Therapeutics, Inc. | Protutijela koja se vežu na csf1r |
| RU2658603C2 (ru) | 2011-12-15 | 2018-06-21 | Ф.Хоффманн-Ля Рош Аг | Антитела против человеческого csf-1r и их применения |
| KR20140127855A (ko) | 2012-02-06 | 2014-11-04 | 제넨테크, 인크. | Csf1r 억제제를 사용하는 조성물 및 방법 |
| AR090263A1 (es) | 2012-03-08 | 2014-10-29 | Hoffmann La Roche | Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma |
| RU2670743C9 (ru) | 2012-05-11 | 2018-12-19 | Файв Прайм Терапьютикс, Инк. | Способы лечения состояний антителами, которые связывают рецептор колониестимулирующего фактора 1 (csf1r) |
| CN107759690A (zh) | 2012-08-31 | 2018-03-06 | 戊瑞治疗有限公司 | 用结合群落刺激因子1受体(csf1r)的抗体治疗病状的方法 |
| US9090697B2 (en) | 2013-03-15 | 2015-07-28 | Bayer Healthcare Llc | Methods for treating bleeding disorders |
| MA39986A (fr) | 2014-04-25 | 2017-03-01 | Vitae Pharmaceuticals Inc | Dérivés de purine en tant qu'inhibiteurs de cd73 pour le traitement du cancer |
| WO2017120508A1 (en) | 2016-01-08 | 2017-07-13 | Arcus Biosciences, Inc. | Modulators of 5'-nucleotidase, ecto and the use thereof |
| HUE064141T2 (hu) | 2017-01-20 | 2024-02-28 | Arcus Biosciences Inc | Azolopirimidin rákkal összefüggõ rendellenességek kezelésére |
| ES2953349T3 (es) | 2017-05-05 | 2023-11-10 | Arcus Biosciences Inc | Derivados de quinazolina-piridina para el tratamiento de trastornos relacionados con el cáncer |
| PL3634417T3 (pl) | 2017-05-17 | 2023-09-25 | Arcus Biosciences, Inc. | Pochodne chinazolino-pirazolowe do leczenia chorób związanych z nowotworem |
| AU2019229978B2 (en) | 2018-03-05 | 2024-05-30 | Arcus Biosciences, Inc. | Arginase inhibitors |
| CN112004541A (zh) * | 2018-03-09 | 2020-11-27 | 艾库斯生物科学有限公司 | 肠道外给药的免疫增强药物 |
| PL3829581T3 (pl) | 2018-07-27 | 2024-07-01 | Arcus Biosciences, Inc. | Antagoniści pirydonu a2r |
| TWI828800B (zh) | 2018-11-16 | 2024-01-11 | 美商阿克思生物科學有限公司 | Arg1及/或arg2之抑制劑 |
| EP3893891A4 (en) | 2018-12-13 | 2022-08-03 | Arcus Biosciences, Inc. | SOLID FORMS OF A CD73 INHIBITOR AND THEIR USE |
| CN113795267A (zh) | 2019-03-12 | 2021-12-14 | 艾库斯生物科学有限公司 | 致癌基因驱动的癌症的治疗 |
| WO2020205527A1 (en) | 2019-03-29 | 2020-10-08 | Arcus Biosciences, Inc. | Treatment of cancer utilizing an identified adenosine fingerprint |
| US11633416B1 (en) | 2020-03-06 | 2023-04-25 | Arcus Biosciences, Inc. | Oral formulations of CD73 compounds |
| KR20230026312A (ko) * | 2020-06-17 | 2023-02-24 | 아르커스 바이오사이언시즈 인코포레이티드 | Cd73 억제제의 결정형 및 이의 용도 |
-
2021
- 2021-06-16 KR KR1020227042950A patent/KR20230026312A/ko active Pending
- 2021-06-16 CA CA3179320A patent/CA3179320A1/en active Pending
- 2021-06-16 JP JP2022577582A patent/JP2023530456A/ja active Pending
- 2021-06-16 EP EP21739852.8A patent/EP4168120A1/en active Pending
- 2021-06-16 AU AU2021292195A patent/AU2021292195A1/en active Pending
- 2021-06-16 US US17/348,833 patent/US11649261B2/en active Active
- 2021-06-16 WO PCT/US2021/037535 patent/WO2021257643A1/en not_active Ceased
- 2021-06-16 CN CN202180042946.2A patent/CN115942977A/zh active Pending
-
2023
- 2023-04-07 US US18/297,398 patent/US12281136B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023530456A5 (https=) | ||
| CA2750413C (en) | Hydroxamic acid derivatives | |
| JP2020111618A5 (https=) | ||
| JP2025023997A (ja) | Ｆａｋ阻害剤およびその併用薬物 | |
| JP2023518286A5 (https=) | ||
| RU2014151565A (ru) | Способ получения n-[5-(3,5-дифторбензил)-1н-индазол-3-ил]-4-(4-метилпиперазин-1-ил)-2-(тетрагидропиран-4-иламино)бензамида | |
| RU2000108431A (ru) | Ингибиторы поли(адф-рибоза) полимеразы ("parp"), способы и фармацевтические композиции для лечения повреждения нервной или сердечно-сосудистой ткани | |
| JP2016503414A5 (https=) | ||
| JP3200421B2 (ja) | 化学療法剤としての新規ビス白金錯体 | |
| JP2024519188A5 (https=) | ||
| JP2021531273A5 (https=) | ||
| TWI829329B (zh) | 組蛋白去乙醯化酶6和熱休克蛋白90之雙重抑制劑 | |
| JP2021501766A5 (https=) | ||
| US20190202826A1 (en) | Phosphotidylinositol 3-Kinase Inhibitors | |
| CN103848815B (zh) | 含脲基片段的4-取代-6-苯基嘧啶衍生物及其制备方法和用途 | |
| CN104327050A (zh) | 一种吖啶酰胺基硫脲类衍生物及其制备方法和用途 | |
| Ge et al. | Discovery and structural-activity relationship of N-benzyl-2-fluorobenzamides as EGFR/HDAC3 dual-target inhibitors for the treatment of trithe ple-negative breast cancer | |
| US10111955B2 (en) | PEG derivative | |
| Fouladdel et al. | Synthesis and cytotoxicity of some biurets against human breast cancer T47D cell line | |
| CN104072624B (zh) | 一种多胺改性高分子药物及其制备方法与作为抗肿瘤药物的应用 | |
| CN102503908B (zh) | 维a酸衍生物、其制备方法、其药物组合物及其在制备抗肿瘤药物中的应用 | |
| CN112585149B (zh) | 膦过渡金属配位化合物、其制造方法和抗癌剂 | |
| CA2456550A1 (en) | Tumour inhibiting cerium compounds | |
| JP5161434B2 (ja) | 抗癌剤 | |
| CN104262331A (zh) | 一种吖啶酰腙类衍生物及其制备方法和用途 |